Paul Peter Tak
Chief Executive Officer at Candel Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Candel Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2026 | Candel Therapeutics Inc. | Open-market sale | −59,379 | $10.46 | $621,104 |
| Sep 10, 2026 | Candel Therapeutics Inc. | Option exercise | +125,000 | $1.55 | $193,750 |
| Sep 10, 2026 | Candel Therapeutics Inc. | Open-market sale | −220,866 | $11.50 | $2,539,959 |
| Jun 25, 2025 | Candel Therapeutics Inc. | Grant or award | +42,826 | $4.67 | $199,997 |
| Mar 19, 2025 | Candel Therapeutics Inc. | Open-market sale | −400 | $9.00 | $3,600 |
| Mar 18, 2025 | Candel Therapeutics Inc. | Open-market sale | −25,772 | $8.77 | $226,020 |
| Jan 15, 2025 | Candel Therapeutics Inc. | Open-market sale | −21,704 | $7.23 | $156,920 |
| Jan 8, 2025 | Candel Therapeutics Inc. | Open-market sale | −21,172 | $8.22 | $174,034 |
| Nov 29, 2024 | Candel Therapeutics Inc. | Open-market sale | −48,847 | $4.56 | $222,742 |
| Nov 21, 2024 | Candel Therapeutics Inc. | Option exercise | +12,900 | $1.55 | $19,995 |
| Jul 17, 2024 | Candel Therapeutics Inc. | Open-market sale | −22,528 | $6.47 | $145,756 |
| Jul 11, 2024 | Candel Therapeutics Inc. | Open-market sale | −20,293 | $5.97 | $121,149 |
| Nov 28, 2023 | Candel Therapeutics Inc. | Shares withheld for tax | −43,443 | $0.90 | $39,099 |
| Nov 26, 2023 | Candel Therapeutics Inc. | Grant or award | +180,108 | — | — |
Questions about Paul Peter Tak
What boards is Paul Peter Tak on?
Paul Peter Tak sits on the board of Candel Therapeutics Inc.
What company is Paul Peter Tak the CEO of?
Paul Peter Tak is Chief Executive Officer of Candel Therapeutics Inc.
How long has Paul Peter Tak served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.